208 related articles for article (PubMed ID: 15574462)
1. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer.
Frigola J; Solé X; Paz MF; Moreno V; Esteller M; Capellà G; Peinado MA
Hum Mol Genet; 2005 Jan; 14(2):319-26. PubMed ID: 15574462
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma.
Kim JC; Koo KH; Roh SA; Cho YK; Kim HC; Yu CS; Kim HJ; Kim JS; Cho MK
Int J Colorectal Dis; 2003 May; 18(3):203-9. PubMed ID: 12673484
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy.
Frigola J; Muñoz M; Clark SJ; Moreno V; Capellà G; Peinado MA
Oncogene; 2005 Nov; 24(49):7320-6. PubMed ID: 16007128
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
5. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
[TBL] [Abstract][Full Text] [Related]
7. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
8. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer.
Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC
J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.
Rodriguez J; Frigola J; Vendrell E; Risques RA; Fraga MF; Morales C; Moreno V; Esteller M; Capellà G; Ribas M; Peinado MA
Cancer Res; 2006 Sep; 66(17):8462-9468. PubMed ID: 16951157
[TBL] [Abstract][Full Text] [Related]
10. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
12. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors.
Ally MS; Al-Ghnaniem R; Pufulete M
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481
[TBL] [Abstract][Full Text] [Related]
13. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
14. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
[TBL] [Abstract][Full Text] [Related]
15. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
[TBL] [Abstract][Full Text] [Related]
16. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
[TBL] [Abstract][Full Text] [Related]
17. O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis.
Menigatti M; Pedroni M; Verrone AM; Borghi F; Scarselli A; Benatti P; Losi L; Di Gregorio C; Schär P; Marra G; Ponz de Leon M; Roncucci L
Oncol Rep; 2007 Jun; 17(6):1421-7. PubMed ID: 17487400
[TBL] [Abstract][Full Text] [Related]
18. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in cancer: too much, but also too little.
Ehrlich M
Oncogene; 2002 Aug; 21(35):5400-13. PubMed ID: 12154403
[TBL] [Abstract][Full Text] [Related]
20. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
